Weight loss and improvements in cardiometabolic outcomes with extended-release phentermine/topiramate treatment in overweight/obese subjects with type 2 diabetes

被引：0

作者：

Astrup, A. V. ^{[1
]}

Oppert, J. -M. ^{[2
]}

Peterson, C. A. ^{[3
]}

机构：

[1] Univ Copenhagen, LIFE, Dept Human Nutr, Frederiksberg, Denmark

[2] Univ Paris 06, Dept Nutr, Paris, France

[3] Vivus Inc, Mountain View, CA USA

来源：

DIABETOLOGIA | 2012年 / 55卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

695

引用

页码：S284 / S285

页数：2

共 50 条

[11] EFFECT OF WEIGHT LOSS (WL) ON CONCOMITANT MEDICATION COSTS IN OBESE/OVERWEIGHT INDIVIDUALS WITH METABOLIC SYNDROME (METS) RECEIVING PHENTERMINE/TOPIRAMATE EXTENDED-RELEASE (PHEN/TPM ER)
Kahan, S.
Karnawat, S.
VALUE IN HEALTH, 2015, 18 (03) : A297 - A297
[12] Weight Loss with VI-0521 (Phentermine/Controlled Release Topiramate) Stops Progression toward Type 2 Diabetes in Obese Non-Diabetic Subjects
Aronne, Louis J.
Peterson, Craig
Troupin, Barbara
Najarian, Tom
Day, Wesley
DIABETES, 2009, 58 : A32 - A32
[13] Improved Cardiometabolic Risk Factors in Overweight/Obese Subjects Receiving Controlled-Release Phentermine/Topiramate (PHEN/TPM CR)
Cheskin, Lawrence J.
Peterson, Craig A.
DIABETES, 2012, 61 : A710 - A710
[14] Weight Loss (WL) With Phentermine and Topiramate Extended-Release (PHEN/TPM ER) and Change in Glycemic Parameters in Overweight and Obese Adults With Dysglycemia and Stratified by Baseline Body Mass Index (BMI)
Ryan, Donna H.
Bowden, Charles H.
DIABETES, 2013, 62 : A540 - A540
[15] Phentermine–topiramate extended-release reduces progression to T2DM
Nature Reviews Endocrinology, 2014, 10 (1) : 4 - 4
[16] Long-term glycaemic effects of weight loss with low-dose, controlled-release phentermine/topiramate (PHEN/TPM CR) in overweight/obese subjects with diabetes
Van Gaal, L. F.
Cheskin, L. J.
Najarian, T.
Day, W. W.
Peterson, C. A.
DIABETOLOGIA, 2011, 54 : S371 - S371
[17] Once-daily, low-dose, controlled-release phentermine/topiramate results in significant clinical improvements in overweight/obese patients with type 2 diabetes
Garvey, W. T.
Troupin, B.
Day, W. W.
DIABETOLOGIA, 2010, 53
[18] EFFECT OF WEIGHT LOSS WITH PHENTERMINE/TOPIRAMATE CR ON ALANINE AMINOTRANSFERASE CONCENTRATIONS IN OVERWEIGHT/OBESE ADULTS
Klein, Samuel
Najarian, Thomas
Bowden, Charles H.
Day, Wesley W.
HEPATOLOGY, 2010, 52 (04) : 651A - 651A
[19] Treatment with VI-0521 (phentermine and topiramate) leads to one year durable glycaemic benefit and weight loss in subjects with type 2 diabetes
Garvey, W. T.
Troupin, B.
Peterson, C.
Najarian, T.
Tam, P.
Day, W.
DIABETOLOGIA, 2009, 52 : S77 - S77
[20] Improvements in Quality of Life (QoL) With Low-Dose, Controlled-Release Phentermine/Topiramate (PHEN/TPM CR) in Overweight/Obese Subjects
Kolotkin, Ronette L.
Peterson, Craig
Gadde, Kishore M.
OBESITY, 2010, 18 : S155 - S155

← 1 2 3 4 5 →